Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

[1]  G. Krassas,et al.  Viral Conjunctivitis Interfering with the Clinical Activity Score and Management of Thyroid Ophthalmopathy , 2006, Orbit.

[2]  G. Hommel,et al.  Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  Tony Carr,et al.  The DAS24: a short form of the Derriford Appearance Scale DAS59 to measure individual responses to living with problems of appearance. , 2005, British journal of health psychology.

[4]  M. Farid,et al.  Psychological disturbance in graves ophthalmopathy. , 2005, Archives of ophthalmology.

[5]  H. Haggerty,et al.  A modified method for measuring uniocular fields of fixation: reliability in healthy subjects and in patients with Graves orbitopathy. , 2005, Archives of ophthalmology.

[6]  J. Heverhagen,et al.  Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  D. O'Shea,et al.  Recent developments in thyroid eye disease , 2004, BMJ : British Medical Journal.

[8]  J. Dunn.  Review of immunosuppressive drug therapy in uveitis , 2004, Current opinion in ophthalmology.

[9]  J. O'dell,et al.  Therapeutic strategies for rheumatoid arthritis. , 2004, The New England journal of medicine.

[10]  L. Blank,et al.  A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  L. Lennard,et al.  Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. , 2004, Rheumatology.

[12]  Alan A Montgomery,et al.  Design, analysis and presentation of factorial randomised controlled trials , 2003, BMC medical research methodology.

[13]  Stephanie Tortu,et al.  Recruitment of heterosexual couples in public health research: a study protocol , 2003, BMC medical research methodology.

[14]  Y. Choong,et al.  Initial management of ocular hypertension and primary open-angle glaucoma: an evaluation of the royal college of ophthalmologists' guidelines , 2003, Eye.

[15]  J. Smolen,et al.  Therapeutic strategies for rheumatoid arthritis , 2003, Nature Reviews Drug Discovery.

[16]  Douglas G Altman,et al.  Analysis and reporting of factorial trials: a systematic review. , 2003, JAMA.

[17]  D. Meyer.  Orbital radiation therapy for Graves’ ophthalmopathy: Author reply , 2003 .

[18]  R. Goldberg,et al.  Orbital radiation therapy for Graves' ophthalmopathy. , 2003, Ophthalmology.

[19]  J. Halligan,et al.  Orbital radiation therapy for Graves' ophthalmopathy. , 2003, Ophthalmology (Rochester, Minn.).

[20]  H. Haddad.  Orbital radiation therapy for Graves' ophthalmopathy. , 2003, Ophthalmology (Rochester, Minn.).

[21]  L. Bartalena.  Orbital radiation therapy for Graves' ophthalmopathy. , 2003, Ophthalmology (Rochester, Minn.).

[22]  W. Wiersinga,et al.  Orbital radiotherapy for Graves’ ophthalmopathy: Useful or useless? Safe or dangerous? , 2003, Journal of endocrinological investigation.

[23]  E. Seidman.  Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. , 2003, Reviews in gastroenterological disorders.

[24]  B. Vainer,et al.  Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity , 2003, European Journal of Clinical Pharmacology.

[25]  C. Terwee,et al.  Long-term effects of Graves' ophthalmopathy on health-related quality of life. , 2002, European journal of endocrinology.

[26]  C. Marcocci,et al.  Management of thyroid eye disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  W. Wiersinga.  Perspective--Part III: retrobulbar irradiation in Graves orbitopathy: the Dutch experience. , 2002, Ophthalmic plastic and reconstructive surgery.

[28]  C. Gorman,et al.  The Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) Study: Lessons Learned , 2002, Ophthalmic plastic and reconstructive surgery.

[29]  M. Kazim.  Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience. , 2002, Ophthalmic plastic and reconstructive surgery.

[30]  J. Kennerdell,et al.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1 , 2002, The British journal of ophthalmology.

[31]  C. Marcocci,et al.  Orbital radiotherapy for Graves' ophthalmopathy. , 2002, Thyroid : official journal of the American Thyroid Association.

[32]  P. Perros,et al.  Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment , 2001, Clinical endocrinology.

[33]  J. Earle,et al.  A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. , 2001, Ophthalmology.

[34]  S. Feldon.  Radiation therapy for Graves' ophthalmopathy: trick or treat? , 2001, Ophthalmology.

[35]  M. Nardi,et al.  Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. , 2001, The Journal of clinical endocrinology and metabolism.

[36]  C. Terwee,et al.  Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO‐QOL) after different treatments , 2001, Clinical endocrinology.

[37]  G. Hommel,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Low- Versus High-Dose Radiotherapy for Graves’ Ophthalmopathy: A Randomized, Single Blind Trial , 2022 .

[38]  C. Terwee,et al.  Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study , 2000, The Lancet.

[39]  C. Marcocci,et al.  Management of Graves' ophthalmopathy: reality and perspectives. , 2000, Endocrine reviews.

[40]  J. Bradley,et al.  Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation. , 1998, Transplantation.

[41]  C. Terwee,et al.  Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL , 2022 .

[42]  M. Power,et al.  Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment , 1998, Psychological Medicine.

[43]  C. Marcocci,et al.  Treating severe Graves' ophthalmopathy. , 1997, Bailliere's clinical endocrinology and metabolism.

[44]  E. Bradbury,et al.  Visibly different: coping with disfigurement , 1997 .

[45]  G. Rose.  Clinical activity score as a guide in the management of patients with Graves' orbitopathy , 1997, Clinical endocrinology.

[46]  W. Wiersinga,et al.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.

[47]  T. Moss.  Individual variation in adjusting to visible differences , 1997 .

[48]  R. Harrad,et al.  Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease , 1997, Eye.

[49]  G. Hommel,et al.  Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy , 1996, Clinical and experimental immunology.

[50]  G. Fick,et al.  Azathioprine and 6-Mercaptopurine in Crohn Disease , 1995, Annals of Internal Medicine.

[51]  G. Fick,et al.  Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. , 1995, Annals of internal medicine.

[52]  L. Blank,et al.  Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy , 1993, The Lancet.

[53]  M. Kamm,et al.  Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. , 1993, Gut.

[54]  P. Perros,et al.  Age and gender influence the severity of thyroid‐associated ophthalmopathy: a study of 101 patients attending a combined thyroid‐eye clinic , 1993, Clinical endocrinology.

[55]  M. Ahern,et al.  A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. , 1991, Australian and New Zealand journal of medicine.

[56]  C. Marcocci,et al.  Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study , 1991, Journal of endocrinological investigation.

[57]  D. Weightman,et al.  Azathioprine in the treatment of thyroid-associated ophthalmopathy. , 1990, Acta endocrinologica.

[58]  M. Prummel,et al.  Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. , 1989, The New England journal of medicine.

[59]  C. Marcocci,et al.  ORBITAL COBALT IRRADIATION COMBINED WITH RETROBULBAR OR SYSTEMIC CORTICOSTEROIDS FOR GRAVES' OPHTHALMOPATHY: A COMPARATIVE STUDY , 1987, Clinical endocrinology.

[60]  C. Gorman,et al.  Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. , 1987, Endocrinology and metabolism clinics of North America.

[61]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[62]  G. Kahaly,et al.  Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study , 1986, European journal of clinical investigation.

[63]  R. Waller,et al.  The Eye and orbit in thyroid disease , 1984 .

[64]  C. Marcocci,et al.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. , 1983, The Journal of clinical endocrinology and metabolism.

[65]  Rundle Ff,et al.  Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. , 1945 .

[66]  C. W. Wilson,et al.  Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. , 1945, Clinical science.